Lataa...
Engineering CAR-T Cells for Improved Function Against Solid Tumors
Genetic engineering T cells to create clinically applied chimeric antigen receptor (CAR) T cells has led to improved patient outcomes for some forms of hematopoietic malignancies. While this has inspired the biomedical community to develop similar strategies to treat solid tumor patients, challenges...
Tallennettuna:
| Julkaisussa: | Front Immunol |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Frontiers Media S.A.
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6217729/ https://ncbi.nlm.nih.gov/pubmed/30420856 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2018.02493 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|